Skip to main content
. 2021 Mar 11;11:5637. doi: 10.1038/s41598-021-85051-6

Figure 4.

Figure 4

Impact of NNMTi treatment combined with LD switch on EWAT metabolome and associated pathways regulated in DIO mice. Schematic illustration of pathways modulated by NNMTi treatment independently or in conjunction with diet switch. 1-MNA 1-methylnicotinamide, AA amino acid, Ac-CoA acetyl-coenzyme A, AMPK adenosine monophosphate kinase, BCAA branched-chain amino acid, F-6-P fructose-6-phosphate, FA fatty acid, FOXO forkhead box protein O, Glut4 glucose transporter type 4, G-1-P glucose-1-phosphate, G-6-P glucose-6-phosphate, NAD nicotinamide adenine dinucleotide, NAM nicotinamide, NAMPT nicotinamide phosphoribosyltransferase, NF-κB nuclear factor-kappa B, NMN nicotinamide mononucleoside, NMNAT nicotinamide adenylyltransferase, NNMT nicotinamide N-methyltransferase, -O oxidation, PGC-1 α peroxisome proliferator-activated receptor (PPAR) gamma coactivator 1-alpha, SAH S-adenosyl-L-homocysteine, SAM S-adenosyl-L-methionine, Sirts sirtuins, SIRT1 (NAD-dependent deacetylase) sirtuin 1, TCA tricarboxylic acid.